SCHEMBL25570727

SCHEMBL25570727

O=C(NCc1ccc(OCC(F)(F)F)cc1)N(Cc1ccc(F)cc1)C1CCNCC1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 19/20 0.76
CYP1A2 P05177 2/20 0.61
HTR2C P28335 2/20 0.61
CYP2C19 P33261 2/20 0.61
KCNH2 Q12809 2/20 0.61
HTR2B P41595 1/20 0.61
ABCB11 O95342 1/20 0.58
ADRB2 P07550 1/20 0.58
CHRM2 P08172 1/20 0.58
CHRM1 P11229 1/20 0.58
DRD1 P21728 1/20 0.58
TBXA2R P21731 1/20 0.58
SLC6A2 P23975 1/20 0.58
GPR183 P32249 1/20 0.58
ADRA1A P35348 1/20 0.58
OPRM1 P35372 1/20 0.58
APLNR P35414 1/20 0.58
DRD3 P35462 1/20 0.58
CX3CR1 P49238 1/20 0.58
SLC6A3 Q01959 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25570706 0.89 HTR2A (0.78) HTR2ACYP1A2HTR2CCYP2C19KCNH2
SCHEMBL25570686 0.88 HTR2A (0.76) HTR2ACYP1A2HTR2CCYP2C19KCNH2
SCHEMBL25570697 0.87 HTR2A (0.84) HTR2ACYP1A2HTR2CCYP2C19KCNH2
SCHEMBL3716947 0.86 HTR2A (0.73) HTR2ACYP1A2HTR2CCYP2C19KCNH2
SCHEMBL25571423 0.86 HTR2A (0.80) HTR2ACYP1A2HTR2CCYP2C19KCNH2
SCHEMBL3946052 0.86 HTR2A (1.00) HTR2ACYP1A2HTR2CCYP2C19KCNH2
SCHEMBL6203023 0.86 HTR2A (1.00) HTR2ACYP1A2HTR2CCYP2C19KCNH2
Hydrochloric Acid SCHEMBL4096940 0.85 HTR2A (1.00) HTR2ACYP1A2HTR2CCYP2C19KCNH2
SCHEMBL25570733 0.85 HTR2A (0.66) HTR2ACYP1A2HTR2CCYP2C19KCNH2
SCHEMBL3719346 0.84 HTR2A (0.70) HTR2ACYP1A2HTR2CCYP2C19KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4186893-A1 5-HT2A RECEPTOR INHIBITOR OR INVERSE AGONIST, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Geneora Pharma (Shijiazhuang) Co., Ltd. (CN) 2023-05-31 EP disclosed